Lower tumor volume was observed in responding (58.1 cm 3 ) than in non-responding patients (110.8 cm 3 ), though this did not reach statistical significance ( 24 ).
← all excerpts
Current and Future Role of Medical Imaging in Guiding the Management of Patients With Relapsed and Refractory Non-Hodgkin Lymphoma Treated With CAR T-Cell Therapy.
1
—
—